Author Question: In a study in which participants are tricked into believing that they caused harm to someone else, a ... (Read 33 times)

colton

  • Hero Member
  • *****
  • Posts: 627
In a study in which participants are tricked into believing that they caused harm to someone else, a researcher is obligated to make sure that the participants are told about the true nature of the study before they leave and also must make sure that the participants do not feel badly about their behavior. These two obligations are referred to as
 
  a. informed consent and debriefing.
  b. debriefing and protection from harm.
  c. protection from harm and confidentiality.
  d. confidentiality and informed consent.

Question 2

After Mr. Flay has finished filling out a survey that he thought was on cooking skills, he is told that the actual purpose of the survey was to assess his intelligence. This best represents the concept of
 
  a. informed consent.
  b. debriefing.
  c. protection from harm.
  d. confidentiality.



raili21

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

b

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library